Howe & Rusling’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Howe & Rusling’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,150	Closed	-$79K	–	910
2019 Q1	$79K	Buy	+4,150	New	+$67.3K	0.01%	249
2014 Q2	–	Sell	-4,150	Closed	-$54K	–	993
2014 Q1	$54K	Buy	+4,150	New	+$64.9K	0.01%	314
2013 Q3	–	Sell	-4,150	Closed	-$42K	–	958
2013 Q2	$42K	Buy	+4,150	New	+$43.6K	0.01%	369

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Howe & Rusling's OSIR Position: Q2 2019 in Review

Howe & Rusling sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 4,150 shares — an estimated $79K sold.

Howe & Rusling first reported a position in OSIR in Q2 2013 and held it in 3 quarters. The position peaked at $79K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Howe & Rusling reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Howe & Rusling sold 4,150 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $79K.
Howe & Rusling first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
Howe & Rusling's Osiris Therapeutics, Inc. Common Stock position peaked at $79K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Howe & Rusling's 13F filing for Q2 2019, filed 12 Aug 2019.